|
Teva in $40bn push for Mylan as
pharma frenzy heats up
--------------
Teva, the largest generic
drugmaker in the world, set the stage for the biggest pharma deal of the year by
launching an unsolicited $40bn offer to buy its nearest rival
Mylan.
梯瓦制藥向邁蘭發起巨額收購要約
--------------
世界最大的仿制藥制造商梯瓦(Teva)向其最大競爭對手邁蘭(Mylan)發出400億美元的主動收購要約，此舉為今年醫藥行業最大一筆并購交易的上演搭好了舞臺。
|
